SHC - McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount
2024-02-08 08:40:00 ET
Summary
- In a vacuum, SHC screens as my ideal type of business.
- SHC is diversified across almost all major medical device and pharmaceutical manufacturers, boasts a 100% retention rate.
- I estimate SHC will earn $700MM in 2026 EBITDA and $1.50 in 2026 EPS.
The following segment was excerpted from this fund letter.
Sotera Health Company ( SHC )
In a vacuum, SHC screens as my ideal type of business: one half of a duopoly market with good long-term growth where the product sold is mission critical to customers, with high switching costs, yet the product's cost is immaterial to their customers....
McIntyre Partnerships - Sotera Health Company: A Notable Outlier At A Discount